Nanospectra Biosciences

Houston, United States

Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.

$6.1M raised

Mar 2023

Venture - Series Unknown

Biotechnology Health Care Life Science Pharmaceutical

Top Investors

Sirtex Medical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nanospectra Biosciences

How much funding has Nanospectra Biosciences raised?

Nanospectra Biosciences has raised $6.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2023.

Who are Nanospectra Biosciences's investors?

Nanospectra Biosciences's investors include Sirtex Medical.

Where is Nanospectra Biosciences headquartered?

Nanospectra Biosciences is headquartered in Houston, United States.

What does Nanospectra Biosciences do?

Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.

What stage is Nanospectra Biosciences at?

Nanospectra Biosciences is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 15, 2023.

MLA

"Nanospectra Biosciences — Funding & Investors." VCBacked, March 15, 2023, https://www.vcbacked.co/company/nanospectra-biosciences. Accessed July 2, 2026.

APA

VCBacked. (2023). Nanospectra Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nanospectra-biosciences

Wikipedia (cite web)

{{cite web |title=Nanospectra Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/nanospectra-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 15, 2023.